Showing results (111-120 of 119) with videos related to
Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
JAMA Oncology|April 21, 2017
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma: A Phase 1 Dose-Escalation TrialNabil Ahmed, Vita Brawley, Meenakshi Hegde, et al.Cancer Research Communications|February 20, 2025
A Checkpoint Reversal Receptor Mediates Bipartite Activation and Enhances CAR T-cell FunctionDaniel Landi, Shoba A Navai, Rebecca M Brock, et al.Human Gene Therapy|April 30, 2014
Gene therapy: charting a future course--summary of a National Institutes of Health Workshop, April 12, 2013Marina O'Reilly, Howard J Federoff, Yuman Fong, et al.Pediatric Blood & Cancer|June 22, 2019
Insights into pediatric rhabdomyosarcoma research: Challenges and goalsMarielle E Yohe, Christine M Heske, Elizabeth Stewart, et al.Nature Cancer|April 24, 2024
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trialMeenakshi Hegde, Shoba Navai, Christopher DeRenzo, et al.Cancer|April 7, 2018
CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesionsKenneth L McClain, Jennifer Picarsic, Rikhia Chakraborty, et al.Nature Medicine|April 29, 2020
Locoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymomaLaura K Donovan, Alberto Delaidelli, Sujith K Joseph, et al.BMC Infectious Diseases|September 27, 2025
Assessing SARS-CoV-2 vaccine effectiveness in health workers: a cohort study conducted during the pandemic decline phase in five hospitals, affiliated to Al-Azhar University- EgyptZeinab Nabil Ahmed Said, Iman I Salama, Samy Zaky, et al.Cell|July 6, 2024
Early rhombic lip Protogenin+ve stem cells in a human-specific neurovascular niche initiate and maintain group 3 medulloblastomaAbhirami Visvanathan, Olivier Saulnier, Chuan Chen, et al.Pageof 12